Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2010

Feb 10, 2010

34301_dirs_2010-02-10_7fcdbe69-fe72-4380-9031-50a489331324.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2010-02-09

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-09 Restricted Stock Award (Common Stock) A 1195 Acquired 140101 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-09 Non-Qualified Stock Option (right to buy) $6.84 A 20000 Acquired 2020-02-09 Common Stock (20000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 20911 Indirect
Common Stock 34909 Indirect

Footnotes

F1: The Restricted Stock Award ("Award") vests in full on December 31, 2010, unless Mr. Rickey voluntarily resigns prior to 12/31/10, or he is nominated, but declines to stand for re-election at the Company's 2010 Annual Meeting. Vesting of the Award will be accelerated upon Mr. Rickey's death or failure to be re-elected at the Company's 2010 Annual Meeting.

F2: These securities are owned by David Rickey, TTEE FBO the David Rickey Trust.

F3: These securities are owned by the Dave Rickey and Daughters Foundation.

F4: These securities are owned by David M Rickey, Trustee FBO The Rickey Annunity Trust.

F5: The stock options vest 1/24th each month from date of grant.